Mice lacking steroid 5α-reductase 1 and 2 were produced by gene targeting and breeding. Male mice without 5α-reductase 2 or without both enzymes had fully formed internal and external genitalia and were fertile, but had smaller prostates and seminal vesicles than controls. T accumulated to high levels in the reproductive tissues of the mutant mice. DHT administration increased seminal vesicle and coagulating gland weights in mice deficient in 5α-reductase 2 and increased the weights of the prostate, seminal vesicle, and coagulating gland in animals deficient in both enzymes. An inhibitor of both 5α-reductases (GI 208335X) decreased prostate and coagulating gland weights of control mice, but had no effect in those lacking 5α-reductase 1 and 2. Castration reduced the sizes of these tissues in animals of all genotypes. Androgen-dependent gene expression was decreased in the seminal vesicles of mice lacking one or more 5α-reductases and was restored by administration of T or DHT. Female mice missing both enzymes exhibited parturition and fecundity defects similar to those of animals without 5α-reductase 1. We conclude that T is the only androgen required for differentiation of the male urogenital tract in mice and that the synthesis of DHT serves largely as a signal amplification mechanism.The formation of the human male phenotype requires T and DHT, which act through the AR to direct the virilization of different genital anlagen (1). T is necessary for differentiation of the Wolffian ducts into the seminal vesicles, epididymes, and ejaculatory ducts, whereas DHT is needed for the differentiation of the urogenital sinus and genital tubercle into the prostate, urethra, penis, and scrotum. The involvement of distinct androgens in these two developmental pathways is most clearly evidenced in patients with defects in the formation of T or DHT. Mutations that decrease the synthesis of T affect both developmental pathways, as T serves as a metabolic precursor of DHT (2). In contrast, a decrease in the synthesis of DHT is associated only with defects in the virilization of the urogenital sinus and genital tubercle (3,4). Studies in male rats with pharmacological inhibitors support a two-androgen model of phenotypic sexual differentiation in this species (5-7); however, it is not clear whether the requirement for T and DHT in the formation of the male phenotype extends across the mammalian class or why this need exists.
HHS Public Access
Author Manuscript Author ManuscriptAuthor Manuscript
Author ManuscriptThe conversion of T to DHT is catalyzed by steroid 5α-reductase, a membrane-bound enzyme that uses NADPH as a cofactor to reduce the Δ 4,5 bonds of various substrates (8).There are two 5α-reductase genes, and their encoded proteins, designated type 1 and type 2, share approximately 50% sequence identity (9). The enzymes have divergent biochemical and pharmacological properties, and they exhibit different tissue-specific and cell typespecific expression patterns that reflect their biological roles. For example, t...